Consistently, the tumor‐targeted inhibition of EVs secretion also abrogated I/R‐induced injury, as indicated by decreased LDH release (Figure 3j), cTnI levels (Figure 3k), and ROS accumulation (Figure 3l). This evidence concerns the gene TNNI3 and neoplasm.